FIELD: chemistry; pharmacology.
SUBSTANCE: invention refers to organic chemistry and pharmacology, namely to a novel compound used for therapy and prevention of metabolic syndrome. Disclosed (2S)-3-(4-{2-[4-(2-{[(1R,4aR,7S)-7-ethynyl-1,4a,7-trimethyl-1,2,3,4,4a,4b,5,6,7,8,10,10a-dodecahydrophenanthren-1-yl]formamido}ethoxy)phenyl]ethoxy}phenyl)-2-ethoxy-propanoic acid as an agent for therapy and prevention of metabolic syndrome.
EFFECT: using the invention provides effective therapy and prevention of metabolic syndrome.
1 cl, 10 dwg, 3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| AGENT FOR INCREASING THE SENSITIVITY OF TISSUES TO INSULIN IN TYPE 2 DIABETES MELLITUS | 2022 |
|
RU2798603C1 |
| N-[3-OXOLUP-28-OYL]-2-(4-(2-(4-((S)-2-ETHOXY-3-PROPANOYL)PHENOXY)ETHYL)PHENOXY)ETHANAMIDE FOR TREATING AND PREVENTING METABOLIC SYNDROME | 2021 |
|
RU2774591C1 |
| GROUND FORM OF (S)-2-ETHOXY-3-[4-(2-{4-METANESULFONYLOXYPHENYL}ETHOXY)PHENYL]PROPANOIC ACID | 2000 |
|
RU2248966C2 |
| 2-((1-(4R-BENZYL)-1H-1,2,3-TRIAZOL-4-YL)METHOXY)-3-METHYL-6-(PROP-1-en-2-YL)CYCLOHEX-3-en-1-ol AS ANTIPARKINSONIAN AGENT | 2023 |
|
RU2812081C1 |
| NEW PEPTIDE INVOLVED IN ENERGY HOMEOSTASIS | 2006 |
|
RU2409590C2 |
| 2-(3-HYDROXY-4-METHOXYPHENYL)-4,7-DIMETHYL-3,4,4a,5,8,8a-HEXAHYDRO-2H-CHROMEN-4,8-DIOL AS ANALGESIC AGENT | 2013 |
|
RU2506079C1 |
| PHARMACEUTICALLY ACCEPTABLE SALTS OF 2-{4-[(3S)-PIPERIDIN-3-YL]PHENYL}-2H-INDAZOLE-7-CARBOXAMIDE | 2009 |
|
RU2495035C2 |
| 2-HYDROXY-4-OXO-4-PHENYL-2-BUTENOATE OF BENZOTHIAZOLYLAMMONIUM, HAVING HYPOGLYCEMIC ACTIVITY | 2009 |
|
RU2412177C2 |
| CRYSTALLINE FORM OF (S)-2-ETHOXY-3-[4-(2-{4-METHANESULFONYLOXYPHENYL}ETHOXY)PHENYL]PROPANOIC ACID | 2000 |
|
RU2268880C2 |
| 2-HYDROXY-4-METHYLPHENYL-4-OXO-2-BUTENOATE OF THIAZONYL AMMONIUM, POSSESSING HYPOGLYCEMIC AND NOOTROPIC ACTIVITY | 2011 |
|
RU2512291C2 |
